{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:08:55Z","timestamp":1793351335825,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T00:00:00Z","timestamp":1613865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81903294"],"award-info":[{"award-number":["No.81903294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No. A2018342"],"award-info":[{"award-number":["No. A2018342"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["NO. 2018030310412"],"award-info":[{"award-number":["NO. 2018030310412"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["NO. 2018030310412"],"award-info":[{"award-number":["NO. 2018030310412"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","award":["No. 21617352"],"award-info":[{"award-number":["No. 21617352"]}],"id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Poor cholesterol efflux capacity (CEC) has been proposed to be an independent risk factor for cardiovascular diseases. However, current evidence is inconsistent, especially in rheumatoid arthritis (RA) patients. This meta-analysis aims to identify whether CEC is impaired or altered by drug therapy in RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The PubMed\/MEDLINE, Embase, Cochrane Library and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      databases were browsed to identify studies on CEC in RA patients. The searches mainly focused on studies in human subjects that were published before November 14, 2020, without any language restrictions. The effect size was pooled by the standardized mean differences and mean differences (SMD &amp; MD) as well as the corresponding 95% confidence intervals (CIs) in a random or fixed effect model. Heterogeneity across the studies was tested using Cochran\u2019s Q test and\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      statistic. Newcastle-Ottawa Scale and the Downs and Black scale (D&amp;B) were applied to evaluate the quality of included studies. The GRADE-system with its 4-grade evidence scale was used to assess the quality of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 11 eligible articles, including 6 observational and 5 interventional studies, were retrieved. The pooled results showed that in patients with RA, CEC was not significantly different than in healthy controls (SMD: -0.34, 95% CI: \u2212\u20090.83 to 0.14), whereas the plasma HDL-C levels was significantly lower (MD: -3.91, 95% CI: \u2212\u20097.15 to \u2212\u20090.68). Furthermore, in the before-after studies, the CEC of RA patients (SMD: 0.20, 95% CI: 0.02 to 0.37) increased, but the plasma HDL-C levels (MD: 3.63, 95% CI: \u2212\u20090.13 to 7.39) remained at a comparable quantity after anti-rheumatic treatment comparing with the baseline. In addition, the funnel plot of included studies displayed a lightly asymmetry, while Egger\u2019s and Begg\u2019s test did not suggest the existence of publication bias. The quality of evidence was rated according to GRADE as moderate to very low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The current meta-analysis demonstrated that HDL-mediated CEC can be improved by the early control of inflammation and anti-rheumatic treatment in RA patients, which is independent of the plasma HDL-C levels. However, the results should be interpreted with caution because of low-quality and limited quantity of evidence. Future randomized controlled trials are needed to determine whether therapeutic strategies to enhance CEC in RA patients have beneficial effects for preventing CVD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-021-01444-6","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T01:03:18Z","timestamp":1613869398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Binbin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8322-3290","authenticated-orcid":false,"given":"Chaoqun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,21]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/39.suppl_2.3","volume":"39","author":"O Sangha","year":"2000","unstructured":"Sangha O. Epidemiology of rheumatic diseases. Rheumatology (Oxford). 2000;39:3\u201312.","journal-title":"Rheumatology (Oxford)"},{"key":"1444_CR2","first-page":"646","volume":"81","author":"AD Woolf","year":"2003","unstructured":"Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646\u201356.","journal-title":"Bull World Health Organ"},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","volume":"7","author":"DP Symmons","year":"2011","unstructured":"Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7:399\u2013408.","journal-title":"Nat Rev Rheumatol"},{"key":"1444_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","volume":"48","author":"C Meune","year":"2009","unstructured":"Meune C, Touze E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2009;48:1309\u201313.","journal-title":"Rheumatology (Oxford)"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. INTERHEART study investigators. Effect of potentially modifiable risk factors associated with MI in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937\u201352.","journal-title":"Lancet."},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ctim.2018.07.001","volume":"40","author":"M Akbari-Fakhrabadi","year":"2018","unstructured":"Akbari-Fakhrabadi M, Heshmati J, Sepidarkish M, Shidfar F. Effect of sumac (Rhus Coriaria) on blood lipids: a systematic review and meta-analysis. Complement Ther Med. 2018;40:8\u201312.","journal-title":"Complement Ther Med"},{"key":"1444_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/19390211.2018.1440685","volume":"16","author":"J Heshmati","year":"2019","unstructured":"Heshmati J, Sepidarkish M, Namazi N, Shokri F, Yavari M, Fazelian S, et al. Impact of dietary calcium supplement on circulating lipoprotein concentrations and Atherogenic indices in overweight and obese individuals: a systematic review. J Diet Suppl. 2019;16:357\u201367.","journal-title":"J Diet Suppl"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejr.2011.10.002","volume":"34","author":"AM Alsalawy","year":"2012","unstructured":"Alsalawy AM, Fathi AI, Kamel RA, Ewis I. Correlation between serum osteoprotegerin and atherosclerotic vascular disorders in rheumatoid arthritis patients. The Egyptian Rheumatologist. 2012;34:35\u201342.","journal-title":"The Egyptian Rheumatologist"},{"key":"1444_CR9","first-page":"845","volume":"3","author":"MT Nurmohamed","year":"2007","unstructured":"Nurmohamed MT. Atherogenic lipid profiles and its management in patients with rheumatoid arthritis. Vasc Health Risk Manag. 2007;3:845\u201352.","journal-title":"Vasc Health Risk Manag"},{"key":"1444_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/ard.2010.135871","volume":"70","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011;70:482\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","volume":"365","author":"WE Boden","year":"2011","unstructured":"Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Desvignes-Nickens P, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255\u201367.","journal-title":"N Engl J Med"},{"key":"1444_CR12","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","volume":"125","author":"RS Rosenson","year":"2012","unstructured":"Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 2012;125:1905\u201319.","journal-title":"Circulation"},{"key":"1444_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3803\/EnM.2017.32.1.41","volume":"32","author":"SJ Jeong","year":"2017","unstructured":"Jeong SJ, Lee MN, Oh GT. The role of macrophage Lipophagy in reverse cholesterol transport. Endocrinol Metab (Seoul). 2017;32:41\u20136.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2015.10.111","volume":"249","author":"C Liu","year":"2016","unstructured":"Liu C, Zhang Y, Ding D, Li X, Yang Y, Li Q, et al. Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: a prospective cohort study. Atherosclerosis. 2016;249:116\u201324.","journal-title":"Atherosclerosis."},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1194\/jlr.D086884","volume":"60","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, Miyazaki O, Iwamoto T, Usui T, Sato R, Hiraishi C, et al. A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol. J Lipid Res. 2019;60:1959\u201367.","journal-title":"J Lipid Res"},{"key":"1444_CR16","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371:2383\u201393.","journal-title":"N Engl J Med"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","volume":"73","author":"N Ronda","year":"2014","unstructured":"Ronda N, Favari E, Borghi MO, Ingegnoli F, Gerosa M, Chighizola C, et al. Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2014;73:609\u201315.","journal-title":"Ann Rheum Dis"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1136\/annrheumdis-2012-202033","volume":"72","author":"A Vivekanandan-Giri","year":"2013","unstructured":"Vivekanandan-Giri A, Slocum JL, Byun J, Tang C, Sands RL, Gillespie BW, et al. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis. Ann Rheum Dis. 2013;72:1725\u201331.","journal-title":"Ann Rheum Dis"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","volume":"71","author":"C Charles-Schoeman","year":"2012","unstructured":"Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Olmos JM, et al. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 2012;71:1157\u201362.","journal-title":"Ann Rheum Dis"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1136\/heartjnl-2015-308953","volume":"103","author":"F O'Neill","year":"2017","unstructured":"O'Neill F, Charakida M, Topham E, McLoughlin E, Patel N, Sutill E, et al. Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis. Heart. 2017;103:766\u201373.","journal-title":"Heart"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcme.2016.08.002","volume":"13","author":"MJ Ormseth","year":"2016","unstructured":"Ormseth MJ, Yancey PG, Yamamoto S, Oeser AM, Gebretsadik T, Shintani A, et al. Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis. IJC Metab Endocr. 2016;13:6\u201311.","journal-title":"IJC Metab Endocr"},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13075-017-1311-3","volume":"19","author":"B Tejera-Segura","year":"2017","unstructured":"Tejera-Segura B, Macia-Diaz M, Machado JD, de Vera-Gonzalez A, Garcia-Dopico JA, NJM O, et al. HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis. Arthritis Res Ther. 2017;19:113.","journal-title":"Arthritis Res Ther"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/art.39039","volume":"67","author":"N Ronda","year":"2015","unstructured":"Ronda N, Greco D, Adorni MP, Zimetti F, Favari E, Hjeltnes G, et al. Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Arthritis Rheumatol. 2015;67:1155\u201364.","journal-title":"Arthritis Rheumatol"},{"key":"1444_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001588","volume":"4","author":"KP Liao","year":"2015","unstructured":"Liao KP, Playford MP, Frits M, Coblyn JS, Iannaccone C, Weinblatt ME, et al. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis. J Am Heart Assoc. 2015;4:e001588.","journal-title":"J Am Heart Assoc"},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/art.39675","volume":"68","author":"MJ Ormseth","year":"2016","unstructured":"Ormseth MJ, Yancey PG, Solus JF, Bridges SL Jr, Curtis JR, Machado JD, et al. Effect of drug therapy on net cholesterol efflux capacity of high-density lipoprotein-enriched serum in rheumatoid arthritis. Arthritis Rheumatol. 2016;68:2099\u2013105.","journal-title":"Arthritis Rheumatol"},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/a-0833-4627","volume":"51","author":"I Ferraz-Amaro","year":"2019","unstructured":"Ferraz-Amaro I, Hern\u00e1ndez-Hern\u00e1ndez MV, Tejera-Segura B, Delgado-Fr\u00edas E, Mac\u00eda-D\u00edaz M, Linton MF, et al. Effect of IL-6 receptor blockade on Proprotein Convertase Subtilisin\/Kexin Type-9 and cholesterol efflux capacity in rheumatoid arthritis patients. Horm Metab Res. 2019;51:200\u20139.","journal-title":"Horm Metab Res"},{"key":"1444_CR27","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses, 2012. Available from: http:\/\/wwwohrica\/programs\/clinical_ epide mi ology\/ oxfordasp."},{"key":"1444_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"52","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377\u201384.","journal-title":"J Epidemiol Community Health"},{"key":"1444_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/2046-4053-1-66","volume":"1","author":"R Sohanpal","year":"2012","unstructured":"Sohanpal R, Hooper R, Hames R, Priebe S, Taylor S. Reporting participation rates in studies of non-pharmacological interventions for patients with chronic obstructive pulmonary disease: a systematic review. Syst Rev. 2012;1:66.","journal-title":"Syst Rev"},{"key":"1444_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the journal of clinical epidemiology. J Clin Epidemiol. 2011;64:380\u20132.","journal-title":"J Clin Epidemiol"},{"key":"1444_CR31","unstructured":"GRADEpro G D T. Grade\u2019s software for summary of findings tables, health technology assessment and guidelines[J]. 2015."},{"key":"1444_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"1444_CR33","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]."},{"key":"1444_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J IntHout","year":"2016","unstructured":"IntHout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6:e010247.","journal-title":"BMJ Open"},{"key":"1444_CR35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jrsm.1345","volume":"10","author":"CC Wang","year":"2019","unstructured":"Wang CC, Lee WC. A simple method to estimate prediction intervals and predictive distributions: summarizing meta-analyses beyond means and confidence intervals. Res Synth Methods. 2019;10:255\u201366.","journal-title":"Res Synth Methods"},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jclinepi.2008.05.014","volume":"62","author":"G Salanti","year":"2009","unstructured":"Salanti G, Ioannidis JP. Synthesis of observational studies should consider credibility ceilings. J Clin Epidemiol. 2009;62:115\u201322.","journal-title":"J Clin Epidemiol"},{"key":"1444_CR37","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u2013101.","journal-title":"Biometrics"},{"key":"1444_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315:629\u201334.","journal-title":"Bmj"},{"key":"1444_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/MOL.0000000000000333","volume":"27","author":"KR Feingold","year":"2016","unstructured":"Feingold KR, Grunfeld C. Effect of inflammation on HDL structure and function. Curr Opin Lipidol. 2016;27:521\u201330.","journal-title":"Curr Opin Lipidol"},{"key":"1444_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193815","volume":"13","author":"R Audo","year":"2018","unstructured":"Audo R, Deckert V, Daien CI, Che H, Elhmioui J, Lemaire S, et al. PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity. PLoS One. 2018;13:e0193815.","journal-title":"PLoS One"},{"key":"1444_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1172\/JCI5578","volume":"103","author":"XC Jiang","year":"1999","unstructured":"Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest. 1999;103:907\u201314.","journal-title":"J Clin Invest"},{"key":"1444_CR42","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1194\/jlr.M011122","volume":"52","author":"P Malik","year":"2011","unstructured":"Malik P, Berisha SZ, Santore J, Agatisa-Boyle C, Brubaker G, Smith JD. Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport. J Lipid Res. 2011;52:951\u20137.","journal-title":"J Lipid Res"},{"key":"1444_CR43","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","volume":"119","author":"FC McGillicuddy","year":"2009","unstructured":"McGillicuddy FC, de la Llera MM, Hinkle CC, Joshi MR, Chiquoine EH, Billheimer JT, et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation. 2009;119:1135\u201345.","journal-title":"Circulation"},{"key":"1444_CR44","doi-asserted-by":"publisher","first-page":"104462","DOI":"10.1016\/j.phrs.2019.104462","volume":"149","author":"J Heshmati","year":"2019","unstructured":"Heshmati J, Morvaridzadeh M, Maroufizadeh S, Akbari A, Yavari M, Amirinejad A, et al. Omega-3 fatty acids supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials. Pharmacol Res. 2019;149:104462.","journal-title":"Pharmacol Res"},{"key":"1444_CR45","doi-asserted-by":"crossref","unstructured":"Mojgan M, Nachvak MS, Agah S, Sepidarkish M, Dehghanid F, Rahimlou MM, et al. Effect of soy products and Isoflavones on oxidative stress parameters: a systematic review and meta-analysis of randomized controlled trials. Food Res Int. 2020;109578.","DOI":"10.1016\/j.foodres.2020.109578"},{"key":"1444_CR46","doi-asserted-by":"publisher","first-page":"105210","DOI":"10.1016\/j.phrs.2020.105210","volume":"161","author":"M Morvaridzadeh","year":"2020","unstructured":"Morvaridzadeh M, Sadeghi E, Agah S, Nachvak SM, Fazelian S, Moradi F, et al. Effect of melatonin supplementation on oxidative stress parameters: a systematic review and meta-analysis. Pharmacol Res. 2020;161:105210.","journal-title":"Pharmacol Res"},{"key":"1444_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ahj.2016.07.005","volume":"180","author":"M Anastasius","year":"2016","unstructured":"Anastasius M, Kockx M, Jessup W, Sullivan D, Rye KA, Kritharides L. Cholesterol efflux capacity: an introduction for clinicians. Am Heart J. 2016;180:54\u201363.","journal-title":"Am Heart J"},{"key":"1444_CR48","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1093\/eurheartj\/ehv251","volume":"36","author":"MB Mortensen","year":"2015","unstructured":"Mortensen MB, Afzal S, Nordestgaard BG, Falk E. The high-density lipoprotein-adjusted SCORE model worsens SCORE-based risk classification in a contemporary population of 30,824 Europeans: the Copenhagen general population study. Eur Heart J. 2015;36:2446\u201353.","journal-title":"Eur Heart J"},{"key":"1444_CR49","doi-asserted-by":"publisher","first-page":"f6879","DOI":"10.1136\/bmj.f6879","volume":"347","author":"DE Threapleton","year":"2013","unstructured":"Threapleton DE, Greenwood DC, Evans CE, Cleghorn CL, Nykjaer C, Woodhead C, et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2013;347:f6879.","journal-title":"BMJ"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-021-01444-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-021-01444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T12:51:00Z","timestamp":1697892660000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-021-01444-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,21]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1186\/s12944-021-01444-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-97452\/v1","asserted-by":"object"}]},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,21]]},"assertion":[{"value":"5 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"18"}}